RA Capital Management »

Sera Prognostics Inc-a shares owned by RA Capital Management

Quarter-by-quarter ownership of Sera Prognostics Inc-a (SERA) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Sera Prognostics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sera Prognostics Inc-a held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sera Prognostics Inc-a by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $18M 3.0M 5.92
2024-03-31 $18M 2.0M 9.10

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Biogen SH (BIIB)
Eliem Therapeutics SH (ELYM)
Rxsight SH (RXST)
Avidity Biosciences SH (RNA)
Dyne Therapeutics SH (DYN)
Geron Corp SH (GERN)
Pepgen SH (PEPG)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)

View all positions for RA Capital Management

Top funds holding Sera Prognostics Inc-a

Baker Bros. Advisors
RA Capital Management
BlackRock
Vanguard Group
Geode Capital Management
AWM Investment Company
Captrust Financial Advisors
State Street Corporation
Morgan Stanley
Bank of New York Mellon
Citadel Advisors
Ensign Peak Advisors
Bridgeway Capital Management
Perigon Wealth Management
Resolute Capital Asset Partners

View all funds holding Sera Prognostics Inc-a